Skip Navigation

Profile

Mercedes Porosnicu, M.D.Wake Forest Baptist Health

Doctor Rating

4.6 out of 5

80 Ratings
5 Comments
 

Mercedes Porosnicu, M.D.

Associate Professor,

Clinical Interests

Head and Neck Cancers, Head and Neck Oncology

Contact Information

Returning Patient Appointments: 336-713-5440
Department: 336-716-8664

Insurance Accepted »

Additional Languages

French, Romanian

Education & Training

  • M.D., Inst Medicine Lasi-Romania, 1987
  • Residency, Suny-Buffalo Affil Hosps, 1998
  • Fellowship, Hematology And Oncology, University of Miami, 2001
  • Fellowship, University of Miami, 2002
  • Fellowship, University of Miami, 2003

Memberships

  • Am Assn Of Cancer Research
  • Am Soc of Clinical Oncology

NPI Number

  • 1417903584
Mercedes Porosnicu, M.D.

Doctor Rating

4.6 out of 5

80 Ratings
5 Comments
 

Mercedes Porosnicu, M.D.

Associate Professor, Hematology & Oncology
Office of Women in Medicine and Science

Research Interests

Vesicular stomatitis Indiana virus; Head and Neck Neoplasms; Oncolytic Virotherapy; Interferon-beta; Interferon-alpha
More »

Contact Information

Academic: 336-713-4392 | Department: 336-716-8664

Recent Publications

Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages. Yang M, Topaloglu U, Petty WJ, Pagni M, Foley KL, Grant SC, Robinson M, Bitting RL, Thomas A, Alistar AT, Desnoyers RJ, Goodman M, Albright C, Porosnicu M, Vatca M, Qasem SA, DeYoung B, Kytola V, Nykter M, Chen K, Levine EA, Staren ED,.. J Hematol Oncol. 2017;10(1):100.

Reirradiation for second primary or recurrent cancers of the head and neck: dosimetric and outcome analysis. Garg S, Kilburn JM, Lucas JT Jr, Randolph D, Urbanic JJ, Hinson WH, Kearns WT, Porosnicu M, Greven K.. Head Neck. 2016;38(Suppl 1):E961-E969.

Retrospective analysis of cisplatin nephrotoxicity in patients with head and neck cancer receiving outpatient treatment with concurrent high-dose cisplatin and radiation therapy [abstract]. Porosnicu M, Faig J, Taylor RC, Porosnicu KAR, Murea M, Bonomi M, Greven KM.. Int J Radiat Oncol Biol Phys. 2016;94(4):908.

Retrospective analysis of cisplatin nephrotoxicity in patients with head and neck cancer receiving outpatient treatment with concurrent high-dose cisplatin and radiotherapy. Faig J, Haughton M, Taylor RC, D'Agostino RB Jr, Whelen MJ, Porosnicu Rodriguez KA, Bonomi M, Murea M, Porosnicu M.. Am J Clin Oncol. 2016;():.

Interferon beta and interferon alpha 2a differentially protect head and neck cancer cells from vesicular stomatitis virus-induced oncolysis. Westcott MM, Liu J, Rajani K, D'Agostino R Jr, Lyles DS, Porosnicu M.. J Virol. 2015;89(15):7944-7954.

Relation of pre-anthracycline serum bilirubin levels to left ventricular ejection fraction after chemotherapy. Vera T, D'Agostino RB Jr, Jordan JH, Whitlock MC, Melendez GC, Lamar ZS, Porosnicu M, Bonkovsky HL, Poole LB, Hundley WG.. Am J Cardiol. 2015;116(11):1752-1755.

Impact of treatment paradigm and elective nodal coverage on resection status and failure patterns in paranasal sinus tumors [abstract]. Farris M, Lucas JT Jr, Soike M, Page BR, Porosnicu M, Browne JD, McTyre E, Greven KM.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E339-E340.

Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer. Bansal N, Mims J, Kuremsky JG, Olex AL, Zhao W, Yin L, Wani R, Qian J, Center B, Marrs GS, Porosnicu M, Fetrow JS, Tsang AW, Furdui CM.. Antioxid Redox Signal. 2014;21(2):221-236.

Retrospective analysis of the impact of HPV status and smoking on mucositis in patients with oropharyngeal squamous cell carcinoma treated with concurrent chemotherapy and radiotherapy. Vatca M, Lucas JT Jr, Laudadio J, D'Agostino RB, Waltonen JD, Sullivan CA, Rouchard-Plasser R, Matsangou M, Browne JD, Greven KM, Porosnicu M.. Oral Oncol. 2014;50(9):869-876.

Phase 1/2 clinical trial of re-irradiation with pemetrexed and erlotinib followed by maintenance erlotinib for recurrent and second primary squamous cell carcinoma of the head and neck (SCCHN) [abstract]. Lucas JT, Porosnicu M, Plasser R, Sullivan CA, Waltonen JD, Brown JD, Greven KM.. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S179.

Re-irradiation for second primary or recurrent cancers of the head and neck: composite dosimetric measures to evaluate dose to the carotid arteries [abstract]. Garg S, Kilburn JM, Randolph DM, Lucas JT, Urbanic JJ, Porosnicu M, Hinson WH, Kearns WT, Greven KM.. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S480-S481.

Susceptibility of head and neck cancer to an attenuated model of the oncolytic vesicular stomatitis virus expressing suicide genes [abstract]. Porosnicu M, Liu J, Lyles D.. J Clin Oncol. 2010;27(15 Suppl):e14604.

Gefitinig (ZD-1839) with concurrent docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel/gefitinib for patients with stage III NSCLC: a phase I study [abstract]. Blackstock A, Petty J, Oaks T, Porosnicu M, Clark H, Lovato J, Miller A.. J Clin Oncol. 2007;25(18 Suppl):Abstr18165.

Gefitinib (ZD-1839) with concurrent docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel/gefitinib for patients with stage III NSCLC: a phase I study [abstract]. Blackstock AW, Jensen CA, Petty WJ, Oaks T, Porosnicu M, Clark H, Lovato JF, Miller A.. Int J Radiat Oncol Biol Phys. 2007;69(3 Suppl):S476.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Hematology & Oncology

Clinical Interests

Head and Neck Cancers, Head and Neck Oncology
Mercedes Porosnicu, M.D.

Mercedes Porosnicu, M.D.

Associate Professor, Hematology & Oncology
Office of Women in Medicine and Science

Doctor Rating

4.6 out of 5

Mercedes Porosnicu, M.D.80 Ratings
5 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.7
CP explanations of prob/condition
4.7
CP spoke using clear language
4.6
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.8
Patients' confidence in CP
4.8
Time CP spent with patient
4.6
Wait time at clinic
3.8



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

5/28/2017

Very good.

3/8/2017

Very good.

2/15/2017

Wake Forest is an excellent hospital for anyone facing difficult diseases.

1/18/2017

Dr. Porosnicu is an excellent doctor that take time to listen and respond to any concerns that I may have. She take time to make sure I understand what is being said and her approach to my treatment and care.

12/28/2016

Very good.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Six Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsMagnet Hospital RecognitionJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.